Single Peptide5 mg
CJC-1295 with DAC (5 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE5 mg
RECONSTITUTION2.5 mL bacteriostatic water
CONCENTRATION2 mg/mL
ROUTESubcutaneous injection
FREQUENCYOnce weekly
CYCLE LENGTH8–16 weeks
DOSE RANGE1–2 mg weekly
STORAGE−20 °C lyophilized / 2–8 °C reconstituted (use within 30 days)
Overview
CJC-1295 with DAC has an extended half-life of 6–8 days enabling once-weekly dosing for sustained GH/IGF-1 elevation. At 2 mg/mL, 1 unit = 0.01 mL = 20 mcg.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 1 mg | 50 units | 0.50 mL |
| Weeks 5+ | 2 mg | 100 units | 1.00 mL |
Reconstitution Instructions
1.
Draw 2.5 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl/roll until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 30 days.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Peptide Vials (CJC-1295 DAC, 5 mg): 2 vials
- ✓Insulin Syringes (U-100): 8 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 16 swabs
Dosing Protocol
Schedule
Administer once weekly on a consistent day. Do not mix with Ipamorelin in the same syringe.
Cycle Structure
8–12 weeks; follow with 4-week break.
Timing
Consistent weekly day. Any time of day.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Discard if solution becomes cloudy or contains visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.